m+Medelevator.RU
← Поиск публикаций
Allergy · 2019

Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kraft Magdalena, Knop Macarena Pia, Renaudin Jean-Marie, Scherer Hofmeier Kathrin, Pföhler Claudia, Bilò Maria Beatrice, Lang Roland, Treudler Regina, Wagner Nicola, Spindler Thomas, Hourihane Jonathan O'B, Maris Ioana, Koehli Alice, Bauer Andrea, Lange Lars, Müller Sabine, Papadopoulos Nikolaos G, Wedi Bettina, Moeser Anne, Ensina Luis F, Fernandez-Rivas Montserrat, Cichocka-Jarosz Ewa, Christoff George, Garcia Blanca E, Poziomkowska-Gęsicka Iwona, Cardona Victoria, Mustakov Tihomir B, Rabe Uta, Mahler Vera, Grabenhenrich Linus, Dölle-Bierke Sabine, Worm Margitta, Network for Online Registration of Anaphylaxis (NORA)

Аннотация

BACKGROUND: Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction.

METHODS: Data from the Anaphylaxis Registry were analyzed to identify secondary prevention measures offered to patients who experienced anaphylaxis. Our analysis included 7788 cases from 10 European countries and Brazil.

RESULTS: The secondary prevention measures offered varied across the elicitors. A remarkable discrepancy was observed between prevention measures offered in specialized allergy centers (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside the centers: Here, EAACI guideline adherence was only 37%. In the multivariate analysis, the elicitor of the reaction, age of the patient, mastocytosis as comorbidity, severity of the reaction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe one.

CONCLUSIONS: Based on the low implementation of guidelines concerning secondary prevention measures outside of specialized allergy centers, our findings highlight the importance of these specialized centers and the requirement of better education for primary healthcare and emergency physicians.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты